(Press-News.org) CHICAGO – The anticoagulant dabigatran is associated with an increased risk of myocardial infarction (heart attack) or acute coronary syndrome in a broad spectrum of patients when tested against some other medicines, according to a study published Online First by the Archives of Internal Medicine, one of the JAMA/Archives journals.
"Clinicians should consider the potential of these serious harmful cardiovascular effects with use of dabigatran," the study concludes.
Dabigatran etexilate was approved by the European Medicines Agency in 2008 for prevention of venous thromboembolism (VTE) in adults who have undergone total hip or knee replacement and by the U.S. Food and Drug Administration in 2010 for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), the authors write as background in the study. An original trial suggested a small increased risk of myocardial infarction (MI) with the use of dabigatran compared to warfarin in patients with atrial fibrillation.
Ken Uchino, M.D., and Adrian V. Hernandez, M.D., Ph.D., of the Cleveland Clinic in Ohio, searched the medical literature for randomized controlled trials of dabigatran that reported on MI or acute coronary syndrome (ACS) as secondary outcomes. Seven trials were selected, involving 30,514 participants, for their meta-analysis.
The trials they included were: two studies of stroke prophylaxis in atrial fibrillation, one in acute venous thromboembolism, one in ACS and three trials or short-term prophylaxis of deep venous thrombosis in joint replacement. The control groups included administration of warfarin, enoxaparin or placebo.
"Dabigatran was significantly associated with a higher risk of MI or ACS than that seen with agents used in the control group" (dabigatran, 237 events of 20,000 [1.19 percent] vs. control, 83 events of 10,514 [0.79 percent]), the researchers write.
They note the risk of MI or ACS was similar when using revised results of a previous trial and after the exclusion of short-term trials. The authors comment that they used several meta-analytic methods and association measures and the results were consistent.
"Although the relative risk increase was 33 percent, the absolute risk increase was very small, at 0.27 percent," they write.
They suggest that while dabigatran might not directly increase the risk of MI, it may lack the beneficial effects that warfarin and aspirin have in MI prevention. They note they do not know the pharmacologic mechanism that may result in dabigatran increasing the risk of MI or ACS.
"The overall benefit and risk balance of dabigatran use appears to be favorable in patients with AF because of reduction in ischemic stroke. However, the cardiac risk of dabigatran should be investigated further, especially if it is used in populations at high risk of MI or ACS," the authors conclude.
(Arch Intern Med. Published Online January 9, 2012. doi:10.1001/archinternmed.2011.1666. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Invited Commentary: Dabigatran: Do We Have Sufficient Data?
In an accompanying invited commentary, Jeremy M. Jacobs, M.B.B.S., and Jochanan Stessman, M.D., of the Hadassah-Hebrew University Medical Center and Hebrew University-Hadassah Medical School, Jerusalem, Israel, write: "The robust finding that dabigatran is associated with increased rates of MI is alarming and emphasizes the need for continued critical appraisal of new drugs after phase 3 trials."
"Uchino and Hernandez have drawn our attention to the potential safety issue concerning dabigatran and the risk of MI, extracting data from the small number of available RCTs (randomized controlled trials) amidst a plethora of recent literature. A far wider issue of perhaps deeper concern is the enthusiasm – nearly to the level of euphoria – to embrace the new, which must be restrained by the old aphorism: primum non nocere. Only a balanced view of all high-quality data for dabigatran can permit such an assessment necessary to guide clinical decisions," they conclude.
(Arch Intern Med. Published Online January 9, 2012. doi:10.1001/archinternmed.2011.1721. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
To contact corresponding author Ken Uchino, M.D., call Halle Bishop at 216-445-8592 or email Bishoph@ccf.org. To contact corresponding commentary author Jeremy M. Jacobs, M.B.B.S, email jacobsj@hadassah.org.il.
END
CHICAGO – The use of statins in postmenopausal women is associated with increased diabetes risk, according to a study published Online First by the Archives of Internal Medicine, one of the JAMA/Archives journals.
But researchers note statins address the cardiovascular consequences of diabetes and current American Diabetes Association guidelines for primary and secondary prevention should not change. Likewise, researchers write that guidelines for statin use in nondiabetic populations also should not change.
Annie L. Culver, B. Pharm, Rochester Methodist Hospital, Mayo ...
CHICAGO – A substantial proportion of emergency department eye care in Florida is reimbursed through Medicaid or paid for out of pocket by patients, and those findings may help in strategic planning as the debate over how best to implement the nation's new health care reform law progresses, according to a study published in the Archives of Ophthalmology, one of the JAMA/Archives journals.
The Patient Protection and Affordable Care Act (PPACA) will increase insurance coverage in large part by expanding eligibility for Medicaid, "an already stressed and underfunded system ...
CHICAGO – Replacing visual acuity screenings for new Medicare enrollees with coverage of a dilated eye exam for healthy patients entering the government insurance program for the elderly "would be highly cost-effective," suggests a study being published Online First by the Archives of Ophthalmology, one of the JAMA/Archives journals.
People can enroll in Medicare after they turn 65 and are supposed to receive a visual acuity screening and other preventive health checks as part of a Welcome to Medicare health evaluation within 12 months of enrollment. In 2009, the U.S. ...
COLUMBUS, Ohio – New research shows that infectious disease-fighting drugs could be designed to block a pathogen's entry into cells rather than to kill the bug itself.
Historically, medications for infectious diseases have been designed to kill the offending pathogen. This new strategy is important, researchers say, because many parasites and bacteria can eventually mutate their way around drugs that target them, resulting in drug resistance.
In this study, scientists showed that using an experimental agent to block one type of an enzyme in cell cultures and mice prevented ...
Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published today in Neurology, the medical journal of the American Academy of Neurology.
The study looked at individuals with mild cognitive impairment (MCI), the stage between normal aging and dementia when others begin to notice that an individual is developing mild memory or thinking problems. Many older adults with MCI go on to develop Alzheimer's disease.
The study looked at 74 non-smokers with MCI and an average age of 76. Half of the patients ...
Over the past 10 years, Americans drank more sugar-sweetened beverages than ever—as much as 13 billion gallons a year—making these drinks the largest source of added sugar and excess calories in the American diet and, arguably, the single largest dietary factor in the current obesity epidemic. While many states have a sales tax on soda, experts believe they are too low to impact consumption. In a study conducted at Columbia University Medical Center and the University of California, San Francisco, researchers estimated that if a higher, penny-per-ounce tax were imposed ...
CHICAGO -- A 2010 outbreak of Legionnaires' disease in Wisconsin has been linked to a decorative fountain in a hospital lobby, according to a study published in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
When the outbreak of Legionnaires' disease was detected among eight people in southeast Wisconsin, state and local public health officials worked closely with hospital staff to launch an investigation to determine the source of the outbreak. Legionnaires' disease is a severe and ...
ALBANY, Calif. -- An interactive tool developed by researchers from the USDA Forest Service's Pacific Southwest Research Station (PSW) will help wind energy facility operators make informed decisions on efficient ways to reduce impacts on migratory bats.
Fatalities of migratory bats at wind energy facilities have become a frequent occurrence. Bat migration patterns are poorly understood and the relationship between fatalities at wind energy facilities and migratory behavior are still being studied. Previous research has shown that adjusting the operations of turbines ...
Rice University researchers have figured out what gives armchair nanotubes their unique bright colors: hydrogen-like objects called excitons.
Their findings appear in the online edition of the Journal of the American Chemical Society.
Armchair carbon nanotubes – so named for the "U"-shaped configuration of the atoms at their uncapped tips – are one-dimensional metals and have no band gap. This means electrons flow from one end to the other with little resistivity, the very property that may someday make armchair quantum wires possible.
The Rice researchers show armchair ...
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer. Despite aggressive modes of treatments, myeloma ultimately remains incurable. The disease has a high incidence in the communities served by SUNY Downstate.
The findings, published in a recent issue of Journal of Oncology, are the result of a collaborative effort among researchers working in the laboratory of Olcay Batuman, MD, ...
